Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | MAOB | P27338 | 2/20 | 0.68 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.66 |
| ▸ | PGR | P06401 | 1/20 | 0.66 |
| ▸ | HTR1A | P08908 | 1/20 | 0.66 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | PDE4A | P27815 | 1/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.66 |
| ▸ | DRD3 | P35462 | 1/20 | 0.66 |
| ▸ | SNCA | P37840 | 1/20 | 0.66 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.66 |
| ▸ | ALOX5 | P09917 | 9/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 4/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29402769 | 1.00 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| SCHEMBL29358434 | 1.00 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| Coenzyme Q4 SCHEMBL6279408 | 1.00 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| Ubidecarenone SCHEMBL13026488 | 1.00 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| Ubidecarenone SCHEMBL11901691 | 1.00 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| Ubidecarenone SCHEMBL19858 | 1.00 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| SCHEMBL16393869 | 1.00 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| SCHEMBL5530210 | 1.00 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| Coenzyme Q4 SCHEMBL6279406 | 1.00 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| Coenzyme Q6 SCHEMBL29404151 | 1.00 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120156286-A1 | COMPOSITIONS AND METHODS FOR INCREASED DELIVERY OF COENZYME Q10 | IMAGENETIX, INC. (US) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120156286-A1 | COMPOSITIONS AND METHODS FOR INCREASED DELIVERY OF COENZYME Q10 | SLC25A20, NDUFB10, NDUFA10 | LMNA 479/4885MAOB 529/4885PTGS1 1827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.